drugset / Trial / NCT00867880

Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects

NCT00867880

Phase 1 Completed 12 enrolled Cumberland Pharmaceuticals
RandomizedCrossoverTriple-blindTreatment

Summary

The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of IVIb administered over 5-7 minutes.

Timeline

Start
2009-03
Primary completion
2009-05
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 800 mg Intravenous

Indications

No indication recorded.